Navidea Biopharmaceuticals to Announce Fourth-Quarter and Full-Year 2011 Financial Results on Thursday, March 1, 2012 Feb 27, 2012
Navidea President, Dr. Mark Pykett, to Participate in Panel Discussion on Companion Diagnostics at BIO CEO Feb 13, 2012
Navidea Obtains Positive EMA Guidance for Lymphoseek® (Tilmanocept); Company to Submit Marketing Authorization Application in Europe Feb 1, 2012
Navidea Biopharmaceuticals Enters into Option Agreement to License Parkinson's Disease Imaging Agent Jan 25, 2012
Data on Navidea’s AZD4694 Presented by the Banner Institute at the 6th Annual Human Amyloid Imaging Meeting (HAI) Jan 19, 2012
Navidea Biopharmaceuticals Announces Panel Participation at the Biotech Showcase Conference Jan 9, 2012
